Warwick to conduct breakthrough research on oral cancers in Pakistan

October 06, 2016

One of the deadliest and most prevalent cancers in the Indo-Pakistan region could be treated more effectively, thanks to a new research project being undertaken at the University of Warwick, in collaboration with University Hospitals Coventry and Warwickshire NHS Trust (UHCW) and the Shaukat Khanum Memorial Cancer Hospital & Research Centre (SKM) in Pakistan.

Gathering samples and data from the SKM Cancer Hospital & Research Centre, the project will involve digitally scanning slides of human tissue samples from oral cancer patients at the UHCW, and sophisticated computerised image analysis at Warwick, thereby generating a repository of important information about the different types of cancer cells which can be found in oral cancers in the subcontinent.

Professor Nasir Rajpoot at Warwick's Tissue Image Analytics (TIA) Lab will lead the project, using a revolutionary digital pathology system to analyse image data for cancerous samples from Pakistan's largest cancer hospital and research centre, leading to better diagnosis and treatment of oral cancers.

This information will be used to develop a computerised profiling algorithm, with which pathologists can potentially analyse cancerous tissue samples more accurately, and which can be used for targeted treatment options, and to better stratify oral cancer patients into various risk groups.

With almost 13,000 new cases of oral cancer each year in Pakistan, it is the country's most prevalent cancer, with the second highest mortality rate, likely due to the widespread use of smokeless tobacco, betel quid chewing, and poor oral hygiene. The situation is similar in India, and with people around the world of South Asian heritage - including large populations in Britain.

Professor Rajpoot explains how the project will lead to better diagnosis and treatment of oral cancer patients:

"In this inter-disciplinary project, we will investigate various subgroups of oral cancer patients of the South Asian origin using advanced digital pathology image analysis algorithms recently developed in our lab. The outcomes from this project will shed more light on how oral cancer patients could be better diagnosed and treated in future."

Dr David Snead, Director of the UHCW centre of excellence and a co-investigator on this project, comments that digital pathology will lead to better treatment for oral cancer patients:

"The UHCW Centre of Excellence for Digital Pathology is excited by the prospect of bringing state-of-the-art digital pathology algorithms to the challenging problem of oral cancer. It is one of many areas where we believe this technology is going to deliver improved outcomes for patients."

"Unfortunately, Pakistan has a high incidence of this disease and this represents a great opportunity to make a difference," Dr Snead continues.

Dr Asif Loya, Medical Director at the SKM cancer hospital, says they're looking forward to the project:

"We are excited to be part of this project and look forward to participation in this cutting-edge research which could potentially change the analysis and management of these tumours. This will also introduce state-of-the-art digital imaging capacity at our institution."

The TIA lab at Warwick is one of the leaders in digital pathology image analysis research in the UK, and computerised methods such as this could transform healthcare globally. The project is funded by an EPSRC (a UK funding agency's) Impact Accelerator award to Prof Rajpoot and the team.

University of Warwick

Related Oral Cancer Articles from Brightsurf:

Oral cancer pain predicts likelihood of cancer spreading
Oral cancer is more likely to spread in patients experiencing high levels of pain, according to a team of researchers at NYU College of Dentistry that found genetic and cellular clues as to why metastatic oral cancers are so painful.

Pathogens in the mouth induce oral cancer
Pathogens found in tissues that surround the teeth contribute to a highly aggressive type of oral cancer, according to a study published 1st October in the open-access journal PLOS Pathogens by Yvonne Kapila of the University of California, San Francisco, and colleagues.

Adherence to oral diabetes drugs may improve survival in diabetics with colorectal cancer
Among patients with both colorectal cancer and diabetes in Korea, those who had a high adherence to their oral diabetes medication had a significantly reduced risk of overall mortality compared with those with lower adherence.

Oral apixaban as good as dalteparin for treating cancer-associated clots
For people with cancer, the oral blood thinner apixaban is at least as effective as dalteparin, a low molecular weight heparin given by injection, in preventing a repeat venous thromboembolism (VTE), or blood clot, with no excess in major bleeding events, according to Phase 3 trial results presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).

New study highlights sociodemographic disparities in oral cancer screening rates
Researchers at Brigham and Women's Hospital led a study to examine oral cancer screening rates among those who had been to the dentist within two years, looking at whether sociodemographic factors such as income or race predicted differences in these rates.

Risks of novel oral prostate cancer therapies and pre-existing conditions
Common prostate cancer therapy may increase short-term risk of death in patients with pre-existing cardiovascular conditions.

Oral cancer detection by dentists is significantly on the rise
After examining data gathered over an 11-year period in a first-of-its-kind provincial study, University of Toronto clinician-scientist Marco Magalhaes says that dentists in Ontario are detecting more cases of oral cancer and pre-cancer than ever before -- and it's saving lives.

Discovery of oral cancer biomarkers could save thousands of lives
Oral cancer is known for its high mortality rate in developing countries, but an international team of scientists hope its latest discovery will change that.

How a common oral bacteria makes colon cancer more deadly
Researchers have determined how a type of bacteria commonly found in the mouth accelerates the growth of colon cancer.

Lymph node ratio may predict who lives and dies from oral cavity cancer
Patients with lymph node ratio greater than 10 percent had about 2.5 times greater risk of cancer recurrence and 2.7 times greater risk of death than patients with LNR below 10 percent.

Read More: Oral Cancer News and Oral Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.